Chief Executive of Hong Kong Recognizes Member of IMTE HONG

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
724
Chief Executive of Hong Kong Recognizes Member of IMTE

HONG KONG and NEW YORK, June 06, 2018 (GLOBE NEWSWIRE) -- Integrated Media Technology Limited (ASX:ITL) (NASDAQ: IMTE ) (“IMTE” or the “Company”) today announced that its subsidiary, Marvel Digital Limited (“MDL”), received recognition from Mrs. Carrie Lam, the Chief Executive of Hong Kong, for its glasses-free 3D technology at the Hong Kong Winners 2018 ceremony on June 4, 2018. The Hong Kong Winners ceremony is held annually to recognize Hong Kong companies who won awards at the prestigious International Exhibition of Inventions of Geneva. This ceremony is limited to the invited VIP participants only. This year, MDL was selected as one of the five companies to present its award-winning invention directly to Mrs. Carrie Lam.

“It is an honor to be recognized by the Hong Kong Chief Executive for the prestigious awards in Geneva,” said Dr. Herbert Lee, IMTE’s Chairman and CEO. “Our advance technology continues to be acknowledged worldwide, establishing our position as a leader in the autostereoscopic 3D industry.”

MDL won two awards at the 46 th International Exhibition of Inventions of Geneva, which took place on April 11-15, 2018, for its Advanced Image Rendering Algorithms for Autostereoscopic 3D Displays. The exhibition was organized by the Swiss Federal Government, the State and City of Geneva and the World Intellectual Property Organization – WIPO. It included over 1,000 new inventions and products from more than 800 exhibitors and 42 countries. An international jury selected MDL’s technology based on the commercial potential and the innovative achievement. This also indicates that MDL's sophisticated glasses-free 3D technology and solutions have brought unprecedented innovation to the 3D visual industry and is respected worldwide.

About Integrated Media Technology Limited (“IMTE”)

IMTE is engaged in the investment, development, and commercialization of visual technology with a focus on glasses-free 3D (also known as autostereoscopic 3D) display technology.  Through its subsidiary, Marvel Digital Limited, IMTE designs and sells glasses-free 3D products for the industrial market.  These products include glasses-free 3D digital signage and video wall, 3D conversion equipment, and software for the film/video production industry.  For the consumer market, IMTE through its subsidiary, GOXD Technology Ltd., offers consumer products such as glasses-free 3D digital photo frame, smartphone, tablet, and TV.  IMTE is headquartered in Hong Kong with regional offices in Australia and China.  IMT is traded on the Nasdaq under the symbol “IMTE” and the ASX under the symbol "ITL".  For more information, please visit  www.imtechltd.com .

Safe Harbor Statement

This press release contains certain statements that may include "forward-looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

U.S Investor Relations Contact:  PCG Advisory Group Adam Holdsworth, Managing Director Email: adamh@pcgadvisory.com Phone: +1 646-862-4607

Photos accompanying this announcement are available at

http://www.globenewswire.com/NewsRoom/Attachm...faee6e5e7e

http://www.globenewswire.com/NewsRoom/Attachm...c64113a46f

http://www.globenewswire.com/NewsRoom/Attachm...4ffdd3997b

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 26

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 15

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 31

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 31

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 30

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 25

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 23

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Breast Suite Transforming Cancer Detection and Care

Updated Category News Views 118

Introducing the AI-Driven DeepHealth Breast Suite DeepHealth has recently launched its Breast Suite, a revolutionary set of AI-powered applications that significantly boosts the effectiveness of breast cancer detection and patient care. This suite is part of a broader initiative to improve health informatics and operational efficiency, showcasing DeepHealth's commitment...

Continue Reading
AVATR Unveils Innovative Luxury Electric Vehicle in Munich

Updated Category News Views 193

AVATR Unveils Innovative Luxury Electric Vehicle in Munich At the recent "Brilliant New Horizon AVATR Brand Day" event, the President of AVATR Technology, Mr. Chen Zhuo, shared insights about the brand's identity. He explained that AVATR transcends the typical electric vehicle company image by embracing high-end sophistication, intelligence, and design. Emotional...

Continue Reading
Security Federal Corporation Expands Stock Repurchase Program

Updated Category News Views 128

Security Federal Corporation Unveils New Stock Repurchase Program Security Federal Corporation (the “Company”) (OTCBB: SFDL), which serves as the holding company for Security Federal Bank (the “Bank”), has recently announced an increase in the number of shares it is authorized to repurchase under its existing stock repurchase program. This updated initiative...

Continue Reading
Experience 'Hot Fellas' Bakery: Immersive NYC Event Awaits

Updated Category News Views 379

Unveiling the Hot Fellas Bakery Pop-Up Experience in NYC The beloved storyline of the Max Original series "And Just Like That…" springs to life with an exciting two-day immersive pop-up event. Fans will have the unique opportunity to step into Anthony Marentino's famous 'Hot Fellas' Bakery, inviting them to participate in a fun and delicious experience. Details of the...

Continue Reading
EyePoint Pharmaceuticals Pursues Major Stock Offering for Growth

Updated Category News Views 228

EyePoint Pharmaceuticals Pursues Major Stock Offering EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a leader in developing innovative therapies for patients suffering from serious retinal diseases, has taken a significant step toward advancing its initiatives by announcing a proposed underwritten public offering. The company is set to offer $150 million of its common...

Continue Reading